TURRONE, Rosanna
 Distribuzione geografica
Continente #
NA - Nord America 1.246
EU - Europa 641
AS - Asia 335
OC - Oceania 2
AF - Africa 1
Totale 2.225
Nazione #
US - Stati Uniti d'America 1.241
DE - Germania 186
CN - Cina 158
IT - Italia 127
SG - Singapore 114
UA - Ucraina 80
GB - Regno Unito 60
RU - Federazione Russa 56
FR - Francia 47
FI - Finlandia 32
HK - Hong Kong 30
TR - Turchia 24
IE - Irlanda 21
BE - Belgio 10
CZ - Repubblica Ceca 10
IN - India 8
SE - Svezia 6
CA - Canada 4
AU - Australia 2
RO - Romania 2
DO - Repubblica Dominicana 1
ID - Indonesia 1
LT - Lituania 1
MU - Mauritius 1
NL - Olanda 1
PL - Polonia 1
RS - Serbia 1
Totale 2.225
Città #
Fairfield 200
Woodbridge 133
Ashburn 102
Singapore 100
Houston 88
Cambridge 72
Jacksonville 69
Seattle 69
Chandler 68
Wilmington 58
Dearborn 51
New York 50
Ann Arbor 39
Brescia 36
Princeton 36
Helsinki 31
Hong Kong 30
Nanjing 30
Istanbul 24
Dublin 21
Beijing 14
Shanghai 14
Milan 13
Lancaster 12
Moscow 11
San Diego 11
Brussels 10
Changsha 10
Munich 10
Shenyang 10
Hebei 9
Nanchang 9
Brno 8
Des Moines 7
Los Angeles 7
Mumbai 7
Nürnberg 6
Castelli Calepio 5
Guangzhou 5
Jinan 5
San Giuliano Terme 5
Boardman 4
Jiaxing 4
Ningbo 4
Redwood City 4
Rome 4
Romola 4
San Francisco 4
Toronto 4
Augusta 3
Falkenstein 3
Lodi 3
London 3
Norwalk 3
Rende 3
Taiyuan 3
Campo San Martino 2
Chicago 2
Dallas 2
Frankfurt am Main 2
Kunming 2
La Seyne-sur-Mer 2
Olomouc 2
Palermo 2
Pavia 2
Rho 2
Ronciglione 2
Sassari 2
Taizhou 2
Tianjin 2
Belgrade 1
Berlin 1
Bienno 1
Bucharest 1
Castiglione delle Stiviere 1
Gunzenhausen 1
Haikou 1
Hangzhou 1
Hefei 1
Hounslow 1
Jakarta 1
Leawood 1
Melbourne 1
Monmouth Junction 1
Nanning 1
Pesaro 1
Philadelphia 1
Reston 1
San Cesareo 1
San Mateo 1
Santa Clara 1
Shenzhen 1
Springfield 1
Sulmona 1
Suri 1
Sydney 1
Timisoara 1
Trieste 1
Twickenham 1
Wandsworth 1
Totale 1.606
Nome #
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 165
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 163
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 159
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 156
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 150
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 147
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 146
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 132
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 120
Vascular risk factors and cognition in Parkinson's disease 116
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 112
Natural history and predictors of survival in progressive supranuclear palsy. 105
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 105
TMS for staging and predicting functional decline in frontotemporal dementia 81
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 74
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 52
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 48
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 46
Correlation between brain glucose metabolism (18F-FDG) and cerebral blood flow with amyloid tracers (18F-Florbetapir) in clinical routine: Preliminary evidences 43
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 38
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 29
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 25
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 24
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 21
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 16
Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease 13
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 10
Totale 2.296
Categoria #
all - tutte 11.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020347 0 0 0 0 0 73 70 60 58 54 11 21
2020/2021391 5 79 57 39 14 26 13 29 38 32 44 15
2021/2022196 18 19 7 10 1 13 6 16 15 30 19 42
2022/2023221 21 12 14 12 19 55 9 13 36 9 7 14
2023/2024240 22 6 33 15 10 62 1 10 37 5 7 32
2024/2025281 19 8 7 129 75 43 0 0 0 0 0 0
Totale 2.296